Long Leukocyte Telomere Length at Diagnosis Is a Risk Factor for Dementia Progression in Idiopathic Parkinsonism

被引:25
作者
Degerman, Sofie [1 ]
Domellof, Magdalena [2 ]
Landfors, Mattias [1 ]
Linder, Jan [2 ]
Lundin, Mathias [3 ]
Haraldsson, Susann [1 ]
Elgh, Eva [4 ]
Roos, Goran [1 ]
Forsgren, Lars [2 ]
机构
[1] Umea Univ, Dept Med Biosci, Umea, Sweden
[2] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden
[3] Umea Univ, Dept Stat, S-90187 Umea, Sweden
[4] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden
基金
瑞典研究理事会;
关键词
AGING-ASSOCIATED ALTERATION; LEWY BODY; DISEASE; PATHOGENESIS; CRITERIA; CELLS;
D O I
10.1371/journal.pone.0113387
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Telomere length (TL) is regarded as a marker of cellular aging due to the gradual shortening by each cell division, but is influenced by a number of factors including oxidative stress and inflammation. Parkinson's disease and atypical forms of parkinsonism occur mainly in the elderly, with oxidative stress and inflammation in afflicted cells. In this study the relationship between blood TL and prognosis of 168 patients with idiopathic parkinsonism (136 Parkinson's disease [PD], 17 Progressive Supranuclear Palsy [PSP], and 15 Multiple System Atrophy [MSA]) and 30 controls was investigated. TL and motor and cognitive performance were assessed at baseline (diagnosis) and repeatedly up to three to five years follow up. No difference in TL between controls and patients was shown at baseline, nor any significant difference in TL stability or attrition during follow up. Interestingly, a significant relationship between TL at diagnosis and cognitive phenotype at follow up in PD and PSP patients was found, with longer mean TL at diagnosis in patients that developed dementia within three years.
引用
收藏
页数:14
相关论文
共 27 条
[1]   Telomere Shortening and Alzheimer's Disease [J].
Cai, Zhiyou ;
Yan, Liang-Jun ;
Ratka, Anna .
NEUROMOLECULAR MEDICINE, 2013, 15 (01) :25-48
[2]   Telomere measurement by quantitative PCR [J].
Cawthon, RM .
NUCLEIC ACIDS RESEARCH, 2002, 30 (10) :e47
[3]  
Domellof ME, 2013, THESIS UMEA U MED
[4]   No Evidence for Shorter Leukocyte Telomere Length in Parkinson's Disease Patients [J].
Eerola, Johanna ;
Kananen, Laura ;
Manninen, Kaisa ;
Hellstrom, Olli ;
Tienari, Pentti J. ;
Hovatta, Iiris .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2010, 65 (11) :1181-1184
[5]  
Emre Murat, 2007, Handb Clin Neurol, V83, P401, DOI 10.1016/S0072-9752(07)83018-1
[6]   THE RELEVANCE OF THE LEWY BODY TO THE PATHOGENESIS OF IDIOPATHIC PARKINSONS-DISEASE [J].
GIBB, WRG ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (06) :745-752
[7]   Consensus statement on the diagnosis of multiple system atrophy [J].
Gilman, S ;
Low, PA ;
Quinn, N ;
Albanese, A ;
Ben-Shlomo, Y ;
Fowler, CJ ;
Kaufman, H ;
Klockgether, T ;
Lang, AE ;
Lantos, PL ;
Litvan, I ;
Mathias, CJ ;
Oliver, E ;
Robertson, D ;
Schatz, I ;
Wenning, GK .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 163 (01) :94-98
[8]   Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations [J].
Goetz, CG ;
Poewe, W ;
Rascol, O ;
Sampaio, C ;
Stebbins, GT ;
Counsell, C ;
Giladi, N ;
Holloway, RG ;
Moore, CG ;
Wenning, GK ;
Yahr, MD ;
Seidl, L .
MOVEMENT DISORDERS, 2004, 19 (09) :1020-1028
[9]   A percentage analysis of the telomere length in Parkinson's disease patients [J].
Guan, Jing Zhi ;
Maeda, Toyoki ;
Sugano, Masahiro ;
Oyama, Jun-ichi ;
Higuchi, Yoshihiro ;
Suzuki, Tomokazu ;
Makino, Naoki .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2008, 63 (05) :467-473
[10]   No evidence of substantia nigra telomere shortening in Parkinson's disease [J].
Hudson, Gavin ;
Faini, David ;
Stutt, Andrea ;
Eccles, Martin ;
Robinson, Louise ;
Burn, David J. ;
Chinnery, Patrick F. .
NEUROBIOLOGY OF AGING, 2011, 32 (11) :2107.e3-2107.e5